We are live on ! Find out more

1,470 hedge funds and large institutions have $103B invested in Merck in 2013 Q3 according to their latest regulatory filings, with 78 funds opening new positions, 568 increasing their positions, 619 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more first-time investments, than exits

New positions opened: 78 | Existing positions closed: 53

36% more call options, than puts

Call options by funds: $1.25B | Put options by funds: $918M

1.31% more ownership

Funds ownership: 76.5%77.81% (+1.3%)

1% more capital invested

Capital invested by funds: $102B → $103B (+$1.23B)

1% more funds holding

Funds holding: 1,4591,470 (+11)

8% less repeat investments, than reductions

Existing positions increased: 568 | Existing positions reduced: 619

3% less funds holding in top 10

Funds holding in top 10: 120117 (-3)

Holders
1,470
Holders Change
+11
Holders Change %
+0.75%
% of All Funds
47.65%
Holding in Top 10
117
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-2.5%
% of All Funds
3.79%
New
78
Increased
568
Reduced
619
Closed
53
Calls
$1.25B
Puts
$918M
Net Calls
+$331M
Net Calls Change
-$98.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Capital World Investors
1
Capital World Investors
California
$7.49B -$234M -5,120,983 -3%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$6.88B +$25.6M +561,762 +0.4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$6.73B -$75.4M -1,651,686 -1%
State Street
4
State Street
Massachusetts
$6.19B -$11.6M -254,209 -0.2%
Franklin Resources
5
Franklin Resources
California
$4.17B -$86.1M -1,885,224 -2%
BIT
6
BlackRock Institutional Trust
California
$3.7B -$214M -4,694,420 -5%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$2.92B -$612M -13,404,177 -17%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$2.47B -$138M -3,021,670 -5%
Dodge & Cox
9
Dodge & Cox
California
$2.39B -$26.8M -586,408 -1%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$2.16B -$139M -3,037,082 -6%
Northern Trust
11
Northern Trust
Illinois
$2.09B -$116M -2,540,117 -5%
BFA
12
BlackRock Fund Advisors
California
$1.71B -$4.71M -103,220 -0.3%
JP Morgan Chase
13
JP Morgan Chase
New York
$1.67B -$124M -2,715,728 -7%
Barrow, Hanley, Mewhinney & Strauss
14
Barrow, Hanley, Mewhinney & Strauss
Texas
$1.41B +$15.4M +338,335 +1%
BG
15
BlackRock Group
United Kingdom
$1.35B +$66.6M +1,459,432 +5%
Invesco
16
Invesco
Georgia
$1.3B -$60.9M -1,334,041 -4%
BA
17
BlackRock Advisors
Delaware
$1.23B +$131M +2,862,102 +12%
Goldman Sachs
18
Goldman Sachs
New York
$1.16B +$190M +4,163,881 +19%
Bank of America
19
Bank of America
North Carolina
$1.15B +$76.2M +1,669,419 +7%
Norges Bank
20
Norges Bank
Norway
$1.15B -$43.3M -949,114 -4%
Deutsche Bank
21
Deutsche Bank
Germany
$998M +$9.88M +216,445 +1%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$995M +$2.05M +45,006 +0.2%
TCIM
23
TIAA CREF Investment Management
New York
$855M -$2.58M -56,458 -0.3%
State Farm Mutual Automobile Insurance
24
State Farm Mutual Automobile Insurance
Illinois
$741M -$10.2M -222,385 -1%
Ameriprise
25
Ameriprise
Minnesota
$705M -$152M -3,337,378 -18%

MRK Hedge Fund Activity: Q3 2013 in Review

1,470 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2013, worth a combined $103B — up 1.2% from $102B a quarter earlier.

Buyers outnumbered sellers: 78 funds opened new MRK positions and 53 closed out — a net gain of 25 holders — while 568 added to existing stakes and 619 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $192M. The largest seller was Fidelity Investments, cutting an estimated $612M.

  • 1,470 institutional investors held Merck (MRK) as of Q3 2013, up from 1,459 in Q2 2013.
  • Funds reported $103B of Merck stock for Q3 2013, up 1.2% quarter-over-quarter.
  • 78 funds opened new Merck positions in Q3 2013 and 53 closed out, a net change of +25 holders.
  • The largest Merck buyer in Q3 2013 was Eagle Asset Management, an estimated $192M added.
  • The largest Merck seller in Q3 2013 was Fidelity Investments, an estimated $612M sold.

Based on aggregated 13F filings for Q3 2013.